American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care

Neal J. Meropol(Sidney Kimmel Cancer Center), Lowell E. Schnipper(Sidney Kimmel Cancer Center), Peter A. Ubel(Fox Chase Cancer Center), Thomas J. Smith(Sidney Kimmel Comprehensive Cancer Center), Deborah Schrag(Memorial Sloan Kettering Cancer Center), Robert M. Langdon(Sidney Kimmel Cancer Center), Diane Blum(Sidney Kimmel Cancer Center), Therese M. Mulvey(Sidney Kimmel Cancer Center)
Journal of Clinical Oncology
July 7, 2009
10.1200/jco.2009.23.1183
Cited by 635

Related Papers

How To Build and Interpret a Nomogram for Cancer Prognosis
|Journal of Clinical Oncology|2008|3.4k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k
Diagnosis and Treatment of Metastatic Colorectal Cancer
|JAMA|2021|2.6k
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
|JAMA|2017|2.3k
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k